Different human-like cardiomyopathies associated to β-adrenergic stimulation are experimentally modeled in animals through variations in dose, route, and duration of administration of different cardiotoxic drugs. However, associated changes in the vasculature and their relation to systemic inflammation, and the influence of cardiovascular diseases risk factors (gender and age) upon them are seldom analyzed. Here we studied the effect of age and gender on the vasoreactivity of aortas from mice subjected to in vivo repeated β-adrenergic stimulation with different doses of isoproterenol (ISO) in association with circulating inflammatory cytokines. Young (2 months) and old (18 months) male and female mice received 0 (control), 5, 40, 80 or 160 ...
Westudied the effects ofage and gender on cardiovascular responses to l3-adrenergic stimulation with...
Arterial ageing may be associated with a reduction in vasodilation due to increased reactive oxygen ...
Beta-adrenergic receptor (b-AR)-mediated vasorelaxation declines with age. In the vasculature, b2-AR...
Sex-related differences in cardiovascular diseases are highly complex in humans and model-dependent ...
The present study investigated the influence of gender on the changes underlying endothelial dysfunc...
Background. The age-associated impairment in left ventricular (LV) systolic function appears to be m...
The purpose of the first study was to determine how age and ovarian hormones affect flow-induced vas...
BACKGROUND AND PURPOSE: We investigated the effects of aging on the contributions of NO and endothel...
Information about heart failure with reduced ejection fraction (HFrEF) in women and the potential ef...
Information about heart failure with reduced ejection fraction (HFrEF) in women and the potential ef...
Objectives: Increased central artery stiffness associates with cardiovascular disease. Among other f...
beta-Adrenoceptor-mediated vasorelaxation decreases with age in various vascular beds. The present s...
The time-course for aging-associated effects on vascular reactivity to U46619, a stable analogue of ...
Acute cardiac damage can be induced by isoproterenol injections in animals. The associated inflammat...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Westudied the effects ofage and gender on cardiovascular responses to l3-adrenergic stimulation with...
Arterial ageing may be associated with a reduction in vasodilation due to increased reactive oxygen ...
Beta-adrenergic receptor (b-AR)-mediated vasorelaxation declines with age. In the vasculature, b2-AR...
Sex-related differences in cardiovascular diseases are highly complex in humans and model-dependent ...
The present study investigated the influence of gender on the changes underlying endothelial dysfunc...
Background. The age-associated impairment in left ventricular (LV) systolic function appears to be m...
The purpose of the first study was to determine how age and ovarian hormones affect flow-induced vas...
BACKGROUND AND PURPOSE: We investigated the effects of aging on the contributions of NO and endothel...
Information about heart failure with reduced ejection fraction (HFrEF) in women and the potential ef...
Information about heart failure with reduced ejection fraction (HFrEF) in women and the potential ef...
Objectives: Increased central artery stiffness associates with cardiovascular disease. Among other f...
beta-Adrenoceptor-mediated vasorelaxation decreases with age in various vascular beds. The present s...
The time-course for aging-associated effects on vascular reactivity to U46619, a stable analogue of ...
Acute cardiac damage can be induced by isoproterenol injections in animals. The associated inflammat...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Westudied the effects ofage and gender on cardiovascular responses to l3-adrenergic stimulation with...
Arterial ageing may be associated with a reduction in vasodilation due to increased reactive oxygen ...
Beta-adrenergic receptor (b-AR)-mediated vasorelaxation declines with age. In the vasculature, b2-AR...